A total of 50 healthy individuals and 50 MASH patients were categorized into gender groups, and the results indicated that no significant differences in serum and serum sEV LIMA1 levels between male and female MASH patients (Figure S1L,M, Supporting Information). This evidence concerns the gene LIMA1 and metabolic dysfunction-associated steatohepatitis.